WALTHAM, Mass., Sept. 2, 2014 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics and health information solutions, today has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B). The dividend is payable on October 15, 2014 to holders of record of Series B stock at the close of business on October 1, 2014.
Such payment will cover the amount of all dividends accrued from July 1, 2014 through September 30, 2014.
Alere's global leading rapid diagnostic products and services, as well as its new product development efforts, focus on infectious disease, cardiometabolic disease and toxicology. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit http://www.alere.com/.
SOURCE Alere Inc.